Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cresco Labs Inc (CL.CN)

Cresco Labs Inc (CL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 536,123
  • Shares Outstanding, K 355,581
  • Annual Sales, $ 724,343 K
  • Annual Income, $ -74,438 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.70
  • Price/Sales 0.49
  • Price/Cash Flow 4.42
  • Price/Book 0.78

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +9.09%
on 11/14/25
2.1100 -37.44%
on 10/16/25
-0.5600 (-29.79%)
since 10/14/25
3-Month
1.2100 +9.09%
on 11/14/25
2.2000 -40.00%
on 08/28/25
-0.0500 (-3.65%)
since 08/14/25
52-Week
0.6000 +120.00%
on 06/23/25
2.2000 -40.00%
on 08/28/25
-0.6400 (-32.65%)
since 11/14/24

Most Recent Stories

More News
Cresco Labs Launches Flagship Flower Brand in Germany

New market entry pilots three signature Cresco offerings / Germany/EU Regulatory Notice: This communication is not intended for patients or the general...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), the industry leader in branded cannabis products with a portfolio of America’s...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), today announced the results of its annual general and special meeting of shareholders...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside in Proctorville, Ohio. It is the Company’s sixth dispensary...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing

Transaction Extends Maturity to 2030, Strengthens Balance Sheet and Positions Company for Growth

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Solid Q2 Performance and Debt Refinancing Strengthen Foundation for Long-Term Value Creation

 

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility

Will Reduce Debt and Reinforces Commitment to Prudent Capital Management

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs Announces Strategic Restructuring and Plans to Divest California Operations

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), today announced a strategic restructuring that includes plans to sell its...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)
Cresco Labs to Report Second Quarter 2025 Financial Results on August 7, 2025

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the...

CL.CN : 1.3200 (-12.00%)
CRLBF : 0.9657 (-9.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing,...

See More

Key Turning Points

3rd Resistance Point 1.7833
2nd Resistance Point 1.6467
1st Resistance Point 1.4833
Last Price 1.3200
1st Support Level 1.1833
2nd Support Level 1.0467
3rd Support Level 0.8833

See More

52-Week High 2.2000
Fibonacci 61.8% 1.5888
Fibonacci 50% 1.4000
Last Price 1.3200
Fibonacci 38.2% 1.2112
52-Week Low 0.6000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar